• Light-Controlled RNA Release for Gene Therapy

  2026-08-17

  The 2026 Trends in Biotechnology study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic protein production at the translation stage. By combining reversible light responsiveness with AAV and cell-based delivery strategies, the work demonstrates on-demand regulation in obesity and retinal disease models while highlighting key requirements for clinical translation.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-08-16

  The 2025 reference study shows that naturally occurring angiotensin peptides can enhance SARS-CoV-2 spike protein binding to AXL, ACE2, and neuropilin-1 in receptor-binding assays, with sequence truncation and tyrosine modification influencing activity. Its findings connect renin–angiotensin peptide processing with a potential viral-entry mechanism while emphasizing that enhanced binding is not equivalent to demonstrated infection or disease causation.

• KU-60019: ATM Inhibition Beyond Radiosensitization

  2026-08-15

  KU-60019 is a selective ATM kinase inhibitor for studying glioma radiosensitization, invasion, and metabolic adaptation. This article connects DNA damage response inhibition with macropinocytosis-aware assay design and explains how to interpret combined radiation and nutrient-deprivation experiments.

• SPI1–Wnt5a Signaling in Intracranial Aneurysm

  2026-08-14

  This study identifies SPI1 as a transcriptional driver of intracranial aneurysm formation through repression of Wnt5a and activation of Wnt/β-catenin signaling. Its combined cell, chromatin, pharmacological, and mouse-model evidence links SPI1 to vascular smooth muscle cell phenotypic switching, arterial wall injury, and inflammation.

• Nuclear ERK Spatially Controls Translation in Cardiomyocytes

  2026-08-14

  Uchida et al. identify a spatial translation-control mechanism in which mTORC1 and nuclear ERK regulate distinct aspects of 4EBP1 phosphorylation during concentric cardiac hypertrophy. The study shows that ERK-dependent phosphorylation at 4EBP1 Ser64 redistributes translation toward cardiomyocyte nuclei and promotes interior sarcomeric protein deposition without globally repositioning mRNA.

• Lopinavir: From HIV Potency to Assay Insight

  2026-08-13

  Lopinavir (ABT-378) combines picomolar HIV protease inhibition with a valuable phenotypic research history in coronavirus assays. This guide shows how to interpret target-level potency, serum effects, resistance data, and cross-pathogen screening without confusing distinct experimental endpoints.

• Parathyroid hormone (1-34) (human) in Research

  2026-08-13

  Use this defined PTH (1-34) peptide fragment to connect receptor-proximal signaling assays with bone metabolism research and exploratory kidney assembloid studies. Practical concentration windows, handling guidance, and troubleshooting help distinguish true PTH/PTHrP receptor signaling from peptide, medium, or model variability.

• gamma-Glu-Cys: A Matrix-Aware Assay Guide

  2026-08-12

  Learn how gamma-Glu-Cys functions as a controlled substrate in glutathione metabolism research. This matrix-aware guide connects glutathione synthetase enzyme assay design with findings from Bacillus γ-glutamyl peptide production studies.

• Parathyroid hormone (1-34) (human) in Kidney Assays

  2026-08-12

  Use this defined PTH (1-34) peptide fragment to connect receptor-proximal signaling with spatially organized kidney assembloid phenotypes. The workflow combines sensitive cAMP benchmarking, controlled 3D exposure, and bone-focused validation for more interpretable calcium and tissue-remodeling studies.

• Epinephrine Bitartrate: From Receptor to Assay

  2026-08-11

  Epinephrine Bitartrate is a non-selective adrenergic receptor agonist with applications spanning vascular, cardiac, respiratory, and neurobiology research. This article presents a receptor-to-phenotype framework and explains why clinical vasopressor conversion data should inform, not dictate, laboratory assay design.

• SB 202190 in CRC Organoid Immunology

  2026-08-11

  A translational framework for using SB 202190 as a mechanistic probe in colorectal cancer organoid–T cell models, connecting p38α/p38β signaling with tumor-induced Treg differentiation, inflammation research, apoptosis assays, and biomarker strategy.

• SB-3CT: From MMP9 Biology to Better ECM Assays

  2026-08-10

  SB-3CT is a selective gelatinase inhibitor for dissecting MMP-2 and MMP-9 activity across extracellular matrix models. This article translates new Adamtsl3–MMP9 findings into more rigorous assay strategies while distinguishing demonstrated neurobiology from future SB-3CT applications.

• Nipah Virus Polymerase Complex: Structural Insights

  2026-08-09

  The reference preprint presents cryo-EM and X-ray structures of the Nipah virus L-P polymerase machinery, resolving how the catalytic L protein and tetrameric P protein assemble. The structures define polymerase-domain organization and identify magnesium coordination in the connecting domain, providing a mechanistic framework for Nipah antiviral discovery while leaving inhibitor validation for future work.

• Tacalcitol Monohydrate: Applied Research Workflows

  2026-08-08

  Tacalcitol monohydrate connects VDR-driven gene regulation with practical workflows in keratinocyte, NGF, and colorectal cancer models. This guide shows how to prepare, dose, combine, and troubleshoot the compound for psoriasis-related research and 5-fluorouracil sensitization studies.

• (S)-(+)-Ibuprofen: COX Inhibitor Guide

  2026-08-07

  (S)-(+)-Ibuprofen is the pharmacologically active ibuprofen enantiomer and a useful COX inhibitor for inflammation pathway research. Its reported in vitro COX-2 and COX-1 IC50 values are 1.9 μM and 2.5 μM, respectively, but assay conditions and translational limits must be documented.

16447 records 1/1097 page Next 12345 下5页 Last page